1-2 of 2
Urban Novak
Close
Sort by
Journal Articles

SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma

Clinical Trials & Observations
Anastasios Stathis, Ulrich Mey, Sämi Schär, Felicitas Hitz, Christiane Pott, Nicolas Mach, Fatime Krasniqi, Urban Novak, Christian Schmidt, Karin Hohloch, Dirk Lars Kienle, Dagmar Hess, Alden A. Moccia, Michael Unterhalt, Katrin Eckhardt, Stefanie Hayoz, Gabriela Forestieri, Davide Rossi, Stefan Dirnhofer, Luca Ceriani, Giulio Sartori, Francesco Bertoni, Christian Buske, Emanuele Zucca, Wolfgang Hiddemann
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3911–3920.
https://doi.org/10.1182/bloodadvances.2021006520
Published: 2022
Includes: Supplemental data
Journal Articles

Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial

Clinical Trials & Observations
Rudolf Benz, Kornelius Arn, Martin Andres, Thomas Pabst, Michael Baumann, Urban Novak, Felicitas Hitz, Urs Hess, Reinhard Zenhaeusern, Yves Chalandon, Ulrich Mey, Sabine Blum, Daniel Rauch, Alix O'Meara Stern, Nathan Cantoni, Mario Bargetzi, Elena Bianchi-Papina, Davide Rossi, Jakob Passweg, Andreas Lohri, Simona Berardi, Qiyu Li, Anita Feller, Georg Stussi
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3699–3707.
https://doi.org/10.1182/bloodadvances.2020002160
Published: 2020
Includes: Supplemental data